SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

3

Author notes

    These authors contributed equally: Nina Le Bert, Anthony T. Tan

Affiliations

    t

  1. Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore

    Nina Le Bert, Anthony T. Tan, Kamini Kunasegaran, Christine Y. L. Tham, Morteza Hafezi, Adeline Chia, Melissa Hui Yen Chng, Meiyin Lin, Nicole Tan, Martin Linster, Wan Ni Chia, Lin-Fa Wang, Eng Eong Ooi, Jenny Guek-Hong Low & Antonio Bertoletti

  2. t

  3. Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore, Singapore

    Meiyin Lin & Yee-Joo Tan

  4. t

  5. National Center of Infectious Diseases, Singapore, Singapore

    Mark I-Cheng Chen

  6. t

  7. Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore

    Shirin Kalimuddin & Jenny Guek-Hong Low

  8. t

  9. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

    Paul Anantharajal Tambyah

  10. t

  11. Division of Infectious Disease, University Medicine Cluster, National University Hospital, Singapore, Singapore

    Paul Anantharajal Tambyah

  12. t

  13. Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

    Yee-Joo Tan

  14. t

  15. Singapore Immunology Network, A*STAR, Singapore, Singapore

    Antonio Bertoletti

Corresponding author

Correspondence to Antonio Bertoletti.